GlassScriptPhysician profile
Saman Nazarian
NPI 1710924303
$32,671.82
in general payments reported to CMS, 2019-2025
15 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $12.30 · 2021: $2,273 · 2022: $1,511 · 2023: $11K · 2024: $6,527 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $2,983 · Food and Beverage: $2,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,380.00 |
| Travel and Lodging | $2,982.60 |
| Food and Beverage | $2,079.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,976.00 | 2021-2024 | Carto 3 |
| Biosense Webster, INC. | $9,931.03 | 2020-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Janssen Research & Development, LLC | $2,480.00 | 2023 | |
| Abbott Laboratories | $2,042.38 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite |
| Medtronic, INC. | $1,908.90 | 2024 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,657.79 | 2019-2025 | Farapulse, General - Therapies, Watchman Flx |
| Zoll Respicardia, INC. | $342.98 | 2019-2024 | Remede System |
| Impulse Dynamics (USA) INC. | $98.18 | 2022-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $96.81 | 2019 | |
| Philips North America LLC | $39.25 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $30.52 | 2022-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $22.27 | 2022 | |
| Siemens Medical Solutions USA, INC. | $19.39 | 2019 | |
| Irhythm Technologies, INC. | $15.36 | 2019 | |
| Terumo Medical Corporation | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saman Nazarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.